| [en] Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy |
| English |
| Hotermans, C. [Biogen Idec International GmbH, Zug, Switzerland > > > >] |
| Belachew, Shibeshih [Université de Liège - ULg > Département des sciences cliniques > Neurologie >] |
| Moonen, Gustave [Université de Liège - ULg > > Neurologie Sart Tilman >] |
| Delwaide, Jean [Université de Liège - ULg > > Gastro-Entérologie-Hépatologie >] |
| 2009 |
| Multiple Sclerosis : Clinical & Laboratory Research |
| SAGE Publications |
| 15 |
| 11 |
| 1378-1379 |
| International |
| 1352-4585 |
| London |
| United Kingdom |
| [en] Severe liver dysfunction ; multiple sclerosis ; Drug-Induced Liver Injury/complications/etiology ; Female ; Humans ; Ibuprofen/adverse effects ; Immunosuppressive Agents/adverse effects/therapeutic use ; Interferon Type I, Recombinant/adverse effects/therapeutic use ; Liver Function Tests ; Multiple Sclerosis/complications ; Peptides/adverse effects/therapeutic use |
| Researchers ; Professionals |
| http://hdl.handle.net/2268/66824 |
| also: http://hdl.handle.net/2268/78971 |
| 10.1177/1352458509345910 |